Related Experiment Videos
[Possibilities of systemic fibrinolysis in acute myocardial infarct]
Insights
Systemic fibrinolysis effectively recanalises infarct-related coronary arteries in acute myocardial infarction patients within 3 hours of symptom onset. This treatment, combined with conventional care and timely angiography, guides further therapeutic decisions for improved outcomes.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Context:
- Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide.
- Timely reperfusion therapy is critical for salvaging myocardial tissue and improving patient prognosis.
- Systemic fibrinolysis offers a non-invasive approach to restoring coronary blood flow.
Purpose:
- To evaluate the efficacy of systemic fibrinolysis in achieving recanalisation of the infarct-related coronary artery in AMI patients.
- To assess the impact of symptom-to-treatment interval on fibrinolysis success rates.
- To outline adjunctive medical management and subsequent therapeutic strategies following fibrinolysis.
Summary:
- Systemic fibrinolysis successfully recanalises the infarct-related coronary artery in 60-80% of AMI patients when administered within 3 hours (up to 6 hours) of symptom onset.
- Optimal outcomes require combination therapy including sedation, analgesia, oxygen, and hemodynamic/metabolic optimization with nitroglycerin, calcium antagonists, and beta-blockers.
- Early coronary angiography is essential for guiding decisions on further interventions such as percutaneous transluminal coronary angioplasty, coronary bypass surgery, or continued medical management.
Impact:
- Demonstrates the significant potential of early systemic fibrinolysis in improving AMI treatment success rates.
- Highlights the importance of a time-sensitive, multi-modal approach to AMI management.
- Provides a framework for clinical decision-making regarding reperfusion strategies and subsequent patient care.
Abstract:
Recanalisation of the infarct-related coronary artery could be achieved in 60 to 80% of patients with acute myocardial infarction by means of systemic fibrinolysis, if the interval between the onset of symptoms and the admission to therapy was less than 3 (maximal 6) hours. Fibrinolytic therapy should be combined with an exact conventional treatment in form of sedation, analgesia, oxygen delivery and optimisation of hemodynamics and metabolism with nitroglycerin, calcium antagonists and beta-blockers. Coronary angiography should be performed as soon as possible to decide about further therapy like percutaneous transluminal coronary angioplasty, coronary bypass surgery or medical treatment.